The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial

被引:0
作者
Lise J. Estcourt
Zoe McQuilten
Gillian Powter
Claire Dyer
Eleanor Curnow
Erica M. Wood
Simon J. Stanworth
机构
[1] NHS Blood and Transplant,Radcliffe Department of Medicine
[2] University of Oxford,Transfusion Research Unit, Department of Epidemiology and Preventive Medicine
[3] Monash University,Department of Haematology
[4] Monash Health,undefined
[5] NHS Blood and Transplant Clinical Trials Unit,undefined
[6] NHS Blood and Transplant Statistics and Clinical Studies,undefined
来源
Trials | / 20卷
关键词
Anti-fibrinolytic; Bleeding; Chemotherapy; Haematological malignancy; Haematopoietic stem cell transplant; Leukaemia; Lymphoma; Thrombocytopenia; Tranexamic acid;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 84 条
[1]  
Cameron B(2007)Evaluation of platelet transfusion triggers in a tertiary-care hospital Transfusion 47 206-211
[2]  
Rock G(2005)Compliance with prophylactic platelet transfusion trigger in haematological patients Transfus Med 15 45-48
[3]  
Olberg B(2007)Platelet utilization and the transfusion trigger: a prospective analysis Transfusion 47 201-205
[4]  
Eikenboom JC(2007)National comparative audit of the use of platelet transfusions in the UK Transfus Clin Biol 14 509-513
[5]  
van Wordragen R(2010)Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions Transfus Med Rev 24 163-171
[6]  
Brand A(2011)Platelet transfusions for patients with haematological malignancies: who needs them? Br J Haematol 154 425-440
[7]  
Greeno E(2010)Dose of prophylactic platelet transfusions and prevention of hemorrhage N Engl J Med 362 600-613
[8]  
McCullough J(2013)A no-prophylaxis platelet transfusion strategy for hematologic cancers N Engl J Med 368 1771-1780
[9]  
Weisdorf D(1985)Diagnostic and pathogenetic considerations in transfusion-related acute lung injury Transfusion 25 573-577
[10]  
Qureshi H(2005)Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients Blood 105 4106-4114